AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 88 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $87,888 | +41.0% | 195,089 | -9.3% | 0.00% | – |
| Q1 2023 | $62,347 | -67.8% | 214,989 | -50.0% | 0.00% | – |
| Q4 2022 | $193,448 | +130.3% | 429,978 | +170.4% | 0.00% | – |
| Q3 2022 | $84,000 | +5.0% | 158,989 | 0.0% | 0.00% | – |
| Q2 2022 | $80,000 | -95.6% | 158,989 | -79.8% | 0.00% | – |
| Q1 2022 | $1,810,000 | -49.7% | 787,048 | +3.8% | 0.00% | – |
| Q4 2021 | $3,601,000 | -40.9% | 758,041 | -1.2% | 0.00% | – |
| Q3 2021 | $6,097,000 | +15.6% | 766,941 | +1.2% | 0.00% | – |
| Q2 2021 | $5,272,000 | -7.3% | 757,500 | +5.4% | 0.00% | – |
| Q1 2021 | $5,690,000 | -0.6% | 718,475 | -1.2% | 0.00% | – |
| Q4 2020 | $5,724,000 | +22.9% | 727,334 | +10.7% | 0.00% | – |
| Q3 2020 | $4,657,000 | -22.9% | 656,851 | +0.6% | 0.00% | – |
| Q2 2020 | $6,038,000 | +174.7% | 652,803 | +38.4% | 0.00% | – |
| Q1 2020 | $2,198,000 | -38.1% | 471,698 | +1.5% | 0.00% | – |
| Q4 2019 | $3,551,000 | +7.0% | 464,799 | +7.7% | 0.00% | – |
| Q3 2019 | $3,320,000 | +26.1% | 431,706 | +12.3% | 0.00% | – |
| Q2 2019 | $2,632,000 | +33.5% | 384,270 | +56.8% | 0.00% | – |
| Q1 2019 | $1,972,000 | +7.0% | 245,029 | -0.4% | 0.00% | – |
| Q4 2018 | $1,843,000 | -22.6% | 246,040 | -1.0% | 0.00% | – |
| Q3 2018 | $2,380,000 | +0.6% | 248,512 | +11.2% | 0.00% | – |
| Q2 2018 | $2,366,000 | – | 223,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|